Healthcare -
Biotechnology - NASDAQ - US
$ 313.0
-2.2 %
$ 14.1 B
Market Cap
12.7
P/E
UTHR - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities UTHR - United Therapeutics Corporation
-11.9 M
LAST VALUE
-12.50%
2 YEAR CAGR
-23.64%
5 YEAR CAGR
-8.81%
10 YEAR CAGR